On May 12, 2025, Shineco Inc. completed a share transaction involving the acquisition of 75% of the equity interests in FuWang (HK) International Company Limited from Yi Yang, the sole shareholder. In exchange, Shineco Life Science, a subsidiary of Shineco Inc., paid RMB 63.89 million (approximately US$8.9 million) in cash and issued 3,400,000 shares of the Company's common stock. The transaction was conducted under Rule 902 of Regulation S of the Securities Act of 1933.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shineco Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-009945), on May 13, 2025, and is solely responsible for the information contained therein.